COMMUNIQUÉS West-GlobeNewswire

MDxHealth (R) : MDxHealth annonce des données positives provenant d'une étude paneuropéenne Étude de validation clinique de SelectMDx
18/03/2019
COMMUNIQUÉ DE PRESSE SelectMDx permet une identification précise du cancer de la prostate à faible risque et du cancer de la prostate agressif dans tous les groupes de patients. IRVINE, CA, et HERSTAL, BELGIQUE - 07h00 [...]
Bone Therapeutics to present data at Herbert Fleisch / IFMRS Workshop
18/03/2019
Press release Gosselies, Belgium, 18 March 2019, 7am CET – BONE THERAPEUTICS (Euronext Brussels and Paris: BOTHE), the bone cell therapy company addressing high unmet medical needs in orthopaedics and bone diseases, [...]
DEFINE PCI study finds treatable cause for significant rates of residual ischemia in coronary stent patients
17/03/2019
March 17, 2019 Nearly one in four patients in the study treated with standard of care percutaneous coronary intervention (PCI) had residual ischemia after coronary stent implantation intended to relieve severe blockages [...]
Full Results from PhaseBio Phase 1 Clinical Trial of PB2452 Published in the New England Journal of Medicine and Presented at the American College of Cardiology’s 68th Annual Scientific Session
17/03/2019
PB2452 achieved immediate and sustained reversal of ticagrelor antiplatelet effects Results support continued development of PB2452 as ticagrelor reversal agent MALVERN, Penn. and SAN DIEGO, March 17, 2019 (GLOBE [...]
New Clinical Trial Shows Medtronic TYRX(TM) Envelope Signficantly Reduces Major Infections in Cardiac Implantable Device Patients
17/03/2019
Late-Breaking Trial Results Presented at ACC Scientific Sessions and Published in The New England Journal of Medicine WRAP-IT is the Largest Randomized Global Trial Ever Conducted with Cardiac Implanted Electronic [...]
High Risk of Atherosclerotic Cardiovascular Events Projected in People with Elevated Triglycerides Without Established Atherosclerotic Cardiovascular Disease
16/03/2019
BEDMINSTER, N.J. and DUBLIN, Ireland, March 16, 2019 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN), a pharmaceutical company focused on improving cardiovascular health, announced today the presentation of [...]
Medtronic Evolut Low Risk Trial Meets Primary Endpont
16/03/2019
Less Invasive Evolut(TM) Transcatheter Aortic Valve Replacement (TAVR) System Successful in Clinical Trial When Compared to Open Heart Surgery in Healthier Aortic Stenosis Patients DUBLIN and NEW ORLEANS - March 16, [...]
The Woman’s Hospital of Texas Welcomes Sextuplets!!
16/03/2019
HOUSTON, March 15, 2019 (GLOBE NEWSWIRE) -- The Woman’s Hospital of Texas, an HCA Houston Healthcare Affiliate, which delivers more babies than any other Texas hospital, early this morning welcomed sextuplets, the odds [...]
Praluent® (alirocumab) now approved in European Union to reduce the risk of cardiovascular events in patients with established cardiovascular disease
16/03/2019
France, March 16, 2019 (GLOBE NEWSWIRE) -- Praluent ® (alirocumab) now approved in European Union to reduce the risk of cardiovascular events in patients with established cardiovascular disease Approval is based on [...]
Allergy Standards Ltd deepens footprint in the ‘Bay Area’ as Irish Minister for Health visits
15/03/2019
SAN FRANCISCO, March 15, 2019 (GLOBE NEWSWIRE) -- Allergy Standards Limited (ASL) has been expanding its activities on the West Coast and a visit to San Francisco, Berkeley, and Los Angeles by its CEO Dr. John McKeon [...]
Helix BioPharma Corp. Closes Private Placement, Extends Period to Exercise Warrants and Provides Corporate Update
15/03/2019
RICHMOND HILL, Ontario, March 15, 2019 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX, FSE: HBP) (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates for the prevention and [...]
Adamis Pharmaceuticals Announces 2018 Financial Results and Provides Business Update
15/03/2019
SAN DIEGO, March 15, 2019 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) today announced financial results for the year ended December 31, 2018 and provided a business update. Dr. Dennis J. Carlo [...]
Teligent, Inc. to Present at the 31st Annual ROTH Conference Tuesday March 19, 2019
15/03/2019
BUENA, N.J., March 15, 2019 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey based specialty generic pharmaceutical company, will be presenting at 31 st Annual ROTH Conference March 19, 2019. The [...]
Akcea and Ionis Announce Upcoming Data Presentations at the 2019 American College of Cardiology Meeting (ACC.19)
15/03/2019
Presentations focus on the benefits of treatment with TEGSEDI™ (inotersen) and results show continued efficacy with long-term exposure in the NEURO-TTR open-label extension study BOSTON and CARLSBAD, Calif., March 15, [...]
Bio-Path Holdings to Announce Fourth Quarter and Full Year 2018 Financial Results on March 20, 2019
15/03/2019
HOUSTON, March 15, 2019 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ: BPTH) a biotechnology company leveraging its proprietary DNAbilize ® antisense RNAi nanoparticle technology to develop a portfolio of [...]
Evolus to Release Fourth Quarter and Full Year 2018 Financial Results and Provide a Business Update on Monday, March 18, 2019
15/03/2019
IRVINE, Calif., March 15, 2019 (GLOBE NEWSWIRE) -- Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a customer-centric approach focused on delivering breakthrough products, announced today that it will [...]
Stemline Therapeutics Reports Fourth Quarter 2018 Financial Results
15/03/2019
NEW YORK, March 15, 2019 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq: STML), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel oncology therapeutics, [...]
Nanobiotix 2018 Annual Results
15/03/2019
Paris, France and Cambridge, Massachusetts, USA, March 15, 2019 – NANOBIOTIX (Euronext: NANO – ISIN: FR0011341205 – the “ Company ”), a clinical-stage nanomedicine company pioneering new approaches to the treatment of [...]
Nanobiotix : Résultats Annuels 2018
15/03/2019
Paris, France, et Cambridge, Massachusetts (USA) le 15 mars 2019 – NANOBIOTIX (Euronext: NANO – ISIN: FR0011341205), société française pionnière en nanomédecine développant de nouvelles approches thérapeutiques pour le [...]

Pages